Do you want to read an article? Please log in or register.
Macular ganglion cell-inner plexiform layer thinning as a biomarker of disability progression in relapsing multiple sclerosis
Multiple Sclerosis
Related content
Multiple Sclerosis
Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy
Ann Neurol.
Sotirchos ES, Caldito NG, Filippatou A, Fitzgerald KC, Murphy OC, Lambe J, Nguyen J, Button J, Ogbuokiri E, Crainiceanu CM, Prince JL, Calabresi PA, Saidha S, International Multiple Sclerosis Visual System (IMSVISUAL) Consortium.
doi: 10.1002/ana.25738.
RECOMMENDED
Multiple Sclerosis
Disability progression in relapse-free multiple sclerosis patients on fingolimod versus interferon-beta/glatiramer acetate
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Mult Scler.
von Wyl V, Benkert P, Moser A, Lorscheider J, Décard B, Hänni P, Lienert C, Kuhle J, Derfuss T, Kappos L, Yaldizli Ö
doi: 10.1177/1352458520918489.
Multiple Sclerosis
Association of Rituximab Treatment With Disability Progression Among Patients With Secondary Progressive Multiple Sclerosis
JAMA Neurol.
Naegelin Y, Naegelin P, von Felten S, Lorscheider J, Sonder J, Uitdehaag BMJ, Scotti B, Zecca C, Gobbi C, Kappos L, Derfuss T
doi: 10.1001/jamaneurol.
Multiple Sclerosis
Long-term disability progression in primary progressive multiple sclerosis: a 15-year study
Brain.
Rocca MA, Sormani MP, Rovaris M, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Laroni A, Bergamaschi R, Martinelli V, Comi G, Filippi M
doi: 10.1093/brain/awx250.
Multiple Sclerosis
Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis
JAMA Neurol.
Hughes J, Jokubaitis V, Lugaresi A, Hupperts R, Izquierdo G, Prat A, Girard M, Duquette P, Grand'Maison F, Grammond P, Sola P, Ferraro D, Ramo-Tello C, Trojano M, Slee M, Shaygannejad V, Boz C, Lechner-Scott J, Van Pesch V, Pucci E, Solaro C, Verheul F, Terzi M, Granella F, Spitaleri D, Alroughani R, Jun JK, Fambiatos A, Van der Walt A, Butzkueven H, Kalincik T, MSBase Study Group
doi: 10.1001/jamaneurol.
Multiple Sclerosis
Progressive multiple sclerosis: from pathogenic mechanisms to treatment
Brain.
Correale J, Gaitán MI, Ysrraelit MC, Fiol MP
doi: 10.1093/brain/aww258.
Multiple Sclerosis
Disease-modifying drugs can reduce disability progression in relapsing multiple sclerosis
Brain.
Amato MP, Fonderico M, Portaccio E, Pastò L, Razzolini L, Prestipino E, Bellinvia A, Tudisco L, Fratangelo R, Comi G, Patti F, De Luca G, Brescia Morra V, Cocco E, Pozzilli C, Sola P, Bergamaschi R, Salemi G, Inglese M, Millefiorini E, Galgani S, Zaffaroni M, Ghezzi A, Salvetti M, Lus G, Florio C, Totaro R, Granella F, Vianello M, Gatto M, Di Battista G, Aguglia U, Logullo FO, Simone M, Lucisano G, Iaffaldano P, Trojano M
doi: 10.1093/brain/awaa251.
SPECIAL REPORT
Multiple Sclerosis
Long-Term Real-World Use of Natalizumab Over 10 Years in Relapsing-Remitting Multiple Sclerosis
Multiple Sclerosis
Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
Cell.
Jelcic I, Al Nimer F, Wang J, Lentsch V, Planas R, Jelcic I, Madjovski A, Ruhrmann S, Faigle W, Frauenknecht K, Pinilla C, Santos R, Hammer C, Ortiz Y, Opitz L, Grönlund H, Rogler G, Boyman O, Reynolds R, Lutterotti A, Khademi M, Olsson T, Piehl F, Sospedra M, Martin R
doi: 10.1016/j.cell.2018.08.011.